Long COVID Trial, Recruiting (NCT07659847)

Long COVID Trial, Recruiting NCT07659847 Sponsor: Medical University of Warsaw Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT07659847 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the MIS-C group: People who have previously been diagnosed with a condition called MIS-C (a serious inflammatory condition linked to COVID-19 in children), confirmed using World Health Organization guidelines
For all participants: A parent or legal guardian must provide written agreement for the child to take part, and participants aged 16 or older must also give their own written agreement

Who may not be able to join:

For the MIS-C group: People with a known heart condition, including heart problems present from birth
For the MIS-C group: People with a significant long-term illness that affects their growth, development, or ability to carry out everyday activities
For the control group: People who follow an elimination diet (a diet that cuts out certain foods or food groups)
For the control group: People who take part in competitive athletic training
For the control group: People with a known heart condition, including heart problems present from birth
For the control group: People with a significant long-term illness that affects their growth, development, or ability to carry out everyday activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48 22 317 9231

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07659847

Sponsor: Medical University of Warsaw

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: +48 22 317 9231

More information: https://clinicaltrials.gov/study/NCT07659847

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For the MIS-C group: People who have previously been diagnosed with a condition called MIS-C (a serious inflammatory condition linked to COVID-19 in children), confirmed using World Health Organization guidelines
For all participants: A parent or legal guardian must provide written agreement for the child to take part, and participants aged 16 or older must also give their own written agreement

Who may not be able to join:

For the MIS-C group: People with a known heart condition, including heart problems present from birth
For the MIS-C group: People with a significant long-term illness that affects their growth, development, or ability to carry out everyday activities
For the control group: People who follow an elimination diet (a diet that cuts out certain foods or food groups)
For the control group: People who take part in competitive athletic training
For the control group: People with a known heart condition, including heart problems present from birth
For the control group: People with a significant long-term illness that affects their growth, development, or ability to carry out everyday activities

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Warsaw

Registry

ClinicalTrials.gov

Start date

22 November 2025

Est. completion

31 October 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Aortic (central) systolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov